This inventor holds 11 USPTO granted patents and 3 published patent applications and 2 EPO patents. Top assignees: Glaxo Group Limited, Smithkline Beecham Corporation. Active years: 2003-2009.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2003-2009
Title: The Innovative Journey of Jeremy John Payne
Introduction
Jeremy John Payne, hailing from Stevenage, GB, is a distinguished inventor with a remarkable portfolio of 11 patents. His work primarily revolves around the development of novel compounds, particularly in the realm of anti-inflammatory agents. With a strong scientific background, Payne has significantly contributed to advancements in pharmaceutical chemistry.
Latest Patents
One of his latest innovations includes the patent for "17β-carbothioate 17α-arylcarbonyloxyloxy androstane derivative as anti-inflammatory agents." This patent introduces compounds of formula (I), designed to treat inflammatory and allergic conditions. The invention details the structural components of these compounds, which may include various alkyl and aryl groups, as well as processes for their preparation and therapeutic uses. This groundbreaking work stands to benefit numerous patients with inflammatory conditions, showcasing Payne's commitment to impactful scientific advancements.
Career Highlights
Throughout his career, Jeremy John Payne has made significant contributions while working with prominent pharmaceutical companies, including Glaxo Group Limited and SmithKline Beecham Corporation. His experiences in these organizations have provided him with a robust foundation in research and development, fueling his innovative endeavors.
Collaborations
Payne has collaborated with notable colleagues such as Alan Naylor and Neil Anthony Pegg. Together, these professionals have combined their expertise to push the boundaries of pharmaceutical research, helping to develop innovative solutions and improve therapeutic outcomes.
Conclusion
Jeremy John Payne's contributions to innovation and invention in the pharmaceutical field are noteworthy. With a strong patent portfolio and impactful collaborations, he remains a pivotal figure in the development of anti-inflammatory agents. His work not only highlights his inventive prowess but also his dedication to improving healthcare through scientific advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile